All In Biotech

Drug Trial Radar · NCT06164704

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps on a Background of Nasal Corticosteroids (VIBRANT)

Last checked: Nov 19, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

81

Actual

Start

Dec 18, 2023

Primary completion

Jul 7, 2025

Study completion Jul 22, 2025

Sponsor

Lead sponsor
Upstream Bio Inc.Industry
Sponsor type
Industry
First posted
Dec 11, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to assess the effect of verekitug (UPB-101) on the endoscopically determined size and extend of nasal polyps in participants with chronic rhinosinusitis with nasal polyps (CRSwNP) and to assess the safety and tolerability of verekitug (UPB-101) compared to placebo.

Conditions

  • Chronic Rhinosinusitis With Nasal Polyps

Interventions

  • Verekitug (UPB-101)Drug

    Verekitug (UPB-101) 0.5 mL of formulated solution (100 mg verekitug \[UPB-101\])

  • PlaceboDrug

    Verekitug (UPB-101) matching placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Nasal Polyp Score (NPS) at Week 24Time frame: Baseline, Week 24

Locations

41 sites in 5 countries. Site status is shown where the registry gives one.

  • Sensa Health LA (Sensa Health Clinical Research)

    Los Angeles, California

  • Newport Native MD, Inc.

    Newport Beach, California

  • DaVinci, Research LLC

    Roseville, California

  • Senta Clinic

    San Diego, California

  • University of Missouri

    Columbus, Colorado

  • Western States Clinical Research, Inc.

    Wheat Ridge, Colorado

  • Alfa Medical Research

    Hollywood, Florida

  • Novaceut Clinical Research

    Miami, Florida

  • Well Pharma Medical Research Corp.

    Miami, Florida

  • IMIC Inc.

    Miami, Florida

  • University of South Florida

    Tampa, Florida

  • Treasure Valley Medical Research

    Boise, Idaho

  • The University of Chicago

    Chicago, Illinois

  • Advanced ENT and Allergy

    Louisville, Kentucky

  • Chesapeake Clinical Research, Inc.

    White Marsh, Maryland

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • Northwell Health/Division of Allergy and Immunology

    Great Neck, New York

  • University of Cincinnati Medical Center

    Cincinnati, Ohio

  • Allergy, Asthma & Clinical Research Center

    Oklahoma City, Oklahoma

  • Spartanburg /Greer ENT & Allergy

    Spartanburg, South Carolina

  • Orion Clinical Research

    Austin, Texas

  • Alina Clinical Trials, LLC.

    Dallas, Texas

  • Ears Nose and Throat Associates of Texas

    McKinney, Texas

  • Alamo Ent Associates

    San Antonio, Texas

  • Eastern Virginia Medical School

    Norfolk, Virginia

  • Bellingham Asthma, Allergy & Immunology Clinic

    Bellingham, Washington

  • Allergy, Asthma and Sinus Center, S.C.

    Greenfield, Wisconsin

  • NZZ MUDr Pavel Navratil

    Olomouc, Czech Republic, Czechia

  • Charite Universitaetsmedizin Berlin

    Berlin, Germany

  • Universitaetsklinik Muenster, Klinik fur Hals-, Nasen- und Ohrenheilkunde

    Münster, Germany

  • Universitätsklinik Tuebingen

    Tübingen, Germany

  • Centrum Medyczne Angelius Provita

    Katowice, Poland

  • Centrum Medyczne "All-Med" Badania Kliniczne spolka komandytowa

    Krakow, Poland

  • Centrum Medyczne PROMED

    Krakow, Poland

  • CENTRUM SŁUCHU I MOWY Sp. z o.o.

    Nadarzyn, Poland

  • Centrum Medyczne Lucyna Andrzej Dymek s.c

    Strzelce Opolskie, Poland

  • Centro Médico Teknon

    Barcelona, Spain

  • Hospital Universitario de Jerez de la Frontera

    Cadiz, Spain

  • Hospital Universitario Fundacion Jimenez Diaz (UAM-FJD) Consultas Externas Isaac Peral

    Madrid, Spain

  • Hospital Universitario Ramón y Cajal

    Madrid, Spain

Showing 40 of 41 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.